+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurorehabilitation Therapy, and Neurocognitive Assessment Testing), By Providers, By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 193 Pages
  • January 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5925385
The Global Neurocognitive Assessment And Rehabilitation Market size is expected to reach $23.6 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period.

The rising number of senior people and the growing incidence of neurological disorders mainly drive the market in Asia Pacific. Countries such as China, Japan, South Korea, and India are expected to grow considerably over the forecast period. Consequently, the Asia Pacific region would acquire nearly 25% of the total market share by 2030. Cultural attitudes towards mental health and neurological conditions vary widely in the Asia Pacific region. Initiatives should focus on increasing awareness, reducing stigma, and promoting cultural sensitivity regarding neurocognitive health. Some of the factors impacting the market are increasing prevalence of neurological disorders, growing technology advancement in neurocognitive rehabilitation and high cost of technologies and services.

With the increasing awareness of neurological disorders, there is a growing focus on early detection and intervention. Neurocognitive assessment is crucial in identifying cognitive deficits early, allowing for timely and targeted rehabilitation interventions. The surge in neurological disorders has prompted increased research initiatives focused on understanding the underlying mechanisms, hazard factors, and potential interventions. This research contributes to the development of evidence-based assessment tools and rehabilitation strategies. Thus, the increasing number of neurological diseases is a key driver positively influencing the growth of the market. Additionally, advanced neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), enable more precise and detailed brain structure and function assessment. VR and AR technologies have been incorporated into neurocognitive rehabilitation programs. These immersive technologies create realistic environments for cognitive exercises and rehabilitation activities. Therefore, the growing technological advancement is a driving force behind expanding the market.

Moreover, During the pandemic, there was a rapid and widespread adoption of telehealth solutions. Neurocognitive assessments and rehabilitation services transitioned to virtual platforms, allowing healthcare providers to continue delivering care remotely. The pandemic heightened awareness of mental health challenges, including increased stress, anxiety, and depression. This focus on mental health underscored the importance of including neurocognitive assessments in comprehensive mental health evaluations. The market witnessed a shift toward addressing cognitive well-being as an integral component of overall mental health care. Therefore, the pandemic positively impacted the market.

However, the high cost of neurocognitive assessment technologies and rehabilitation services can limit accessibility, particularly for individuals in lower-income brackets or regions with limited healthcare resources. Moreover, the high cost can contribute to inequality in the delivery of neurocognitive care. Affluent individuals or those with better insurance coverage may have greater access to advanced assessments and rehabilitation services, exacerbating existing healthcare disparities. Due to the above factors, the market growth will be hampered in the coming years.

Provider Outlook

Based on providers, the market is fragmented into rehab centers, hospital & clinics, homecare settings, and physiotherapy centers. The homecare settings segment garnered a significant revenue share in the market. This can be attributed to the increasing demand for in-home neurocognitive assessments driven by convenience for caregivers, preventive care focus, individualized treatment plans, pandemic-related changes, and improved technology integration. Home-based neurocognitive care recognizes the importance of addressing emotional and psychosocial aspects. Telehealth counseling sessions and support groups can be arranged to help individuals cope with the emotional challenges associated with cognitive impairment.

Component Outlook

On the basis of component, the market is segmented into neurocognitive assessment testing and neurorehabilitation therapy. The neurocognitive assessment testing segment acquired a substantial revenue share in the market in 2022. Neurocognitive evaluations often require the cooperation of occupational therapists, speech therapists, neurologists, and neuropsychologists. Implementing this interdisciplinary methodology assures a thorough comprehension of the cognitive well-being of the individual. In some cases, assessments may include measures of emotional and personality functioning. This helps in understanding the impact of cognitive impairments on emotional well-being.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the largest revenue share in the market. This can be attributed to a strong emphasis on research & development in the healthcare sector. The region's robust ecosystem of research institutions, medical universities, and private industry players is expected to foster continuous innovation in neurocognitive technologies. Moreover, collaborations between academia and the healthcare industry facilitate the rapid development and adoption of advanced assessment & rehabilitation tools.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH

Scope of the Study

Market Segments Covered in the Report:

By Component
  • Neurorehabilitation Therapy
  • Neurocognitive Assessment Testing
By Providers
  • Rehab Centers
  • Hospital & Clinics
  • Homecare Settings
  • Physiotherapy Centers
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Cambridge Cognition Holdings plc
  • Cognifit, Inc.
  • Cogstate Ltd.
  • Lumos Labs, Inc. (Lumosity)
  • CNS Vital Signs, LLC
  • Posit Science Corporation
  • BrainCheck, Inc.
  • Constant Therapy Health
  • NeuronUP SL
  • SCHUHFRIED GmbH

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neurocognitive Assessment And Rehabilitation Market, by Component
1.4.2 Global Neurocognitive Assessment And Rehabilitation Market, by Providers
1.4.3 Global Neurocognitive Assessment And Rehabilitation Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Global Neurocognitive Assessment And Rehabilitation Market by Component
4.1 Global Neurorehabilitation Therapy Market by Region
4.2 Global Neurocognitive Assessment Testing Market by Region
Chapter 5. Global Neurocognitive Assessment And Rehabilitation Market by Providers
5.1 Global Rehab Centers Market by Region
5.2 Global Hospital & Clinics Market by Region
5.3 Global Homecare Settings Market by Region
5.4 Global Physiotherapy Centers Market by Region
Chapter 6. Global Neurocognitive Assessment And Rehabilitation Market by Region
6.1 North America Neurocognitive Assessment And Rehabilitation Market
6.1.1 North America Neurocognitive Assessment And Rehabilitation Market by Component
6.1.1.1 North America Neurorehabilitation Therapy Market by Country
6.1.1.2 North America Neurocognitive Assessment Testing Market by Country
6.1.2 North America Neurocognitive Assessment And Rehabilitation Market by Providers
6.1.2.1 North America Rehab Centers Market by Country
6.1.2.2 North America Hospital & Clinics Market by Country
6.1.2.3 North America Homecare Settings Market by Country
6.1.2.4 North America Physiotherapy Centers Market by Country
6.1.3 North America Neurocognitive Assessment And Rehabilitation Market by Country
6.1.3.1 US Neurocognitive Assessment And Rehabilitation Market
6.1.3.1.1 US Neurocognitive Assessment And Rehabilitation Market by Component
6.1.3.1.2 US Neurocognitive Assessment And Rehabilitation Market by Providers
6.1.3.2 Canada Neurocognitive Assessment And Rehabilitation Market
6.1.3.2.1 Canada Neurocognitive Assessment And Rehabilitation Market by Component
6.1.3.2.2 Canada Neurocognitive Assessment And Rehabilitation Market by Providers
6.1.3.3 Mexico Neurocognitive Assessment And Rehabilitation Market
6.1.3.3.1 Mexico Neurocognitive Assessment And Rehabilitation Market by Component
6.1.3.3.2 Mexico Neurocognitive Assessment And Rehabilitation Market by Providers
6.1.3.4 Rest of North America Neurocognitive Assessment And Rehabilitation Market
6.1.3.4.1 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Component
6.1.3.4.2 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Providers
6.2 Europe Neurocognitive Assessment And Rehabilitation Market
6.2.1 Europe Neurocognitive Assessment And Rehabilitation Market by Component
6.2.1.1 Europe Neurorehabilitation Therapy Market by Country
6.2.1.2 Europe Neurocognitive Assessment Testing Market by Country
6.2.2 Europe Neurocognitive Assessment And Rehabilitation Market by Providers
6.2.2.1 Europe Rehab Centers Market by Country
6.2.2.2 Europe Hospital & Clinics Market by Country
6.2.2.3 Europe Homecare Settings Market by Country
6.2.2.4 Europe Physiotherapy Centers Market by Country
6.2.3 Europe Neurocognitive Assessment And Rehabilitation Market by Country
6.2.3.1 Germany Neurocognitive Assessment And Rehabilitation Market
6.2.3.1.1 Germany Neurocognitive Assessment And Rehabilitation Market by Component
6.2.3.1.2 Germany Neurocognitive Assessment And Rehabilitation Market by Providers
6.2.3.2 UK Neurocognitive Assessment And Rehabilitation Market
6.2.3.2.1 UK Neurocognitive Assessment And Rehabilitation Market by Component
6.2.3.2.2 UK Neurocognitive Assessment And Rehabilitation Market by Providers
6.2.3.3 France Neurocognitive Assessment And Rehabilitation Market
6.2.3.3.1 France Neurocognitive Assessment And Rehabilitation Market by Component
6.2.3.3.2 France Neurocognitive Assessment And Rehabilitation Market by Providers
6.2.3.4 Russia Neurocognitive Assessment And Rehabilitation Market
6.2.3.4.1 Russia Neurocognitive Assessment And Rehabilitation Market by Component
6.2.3.4.2 Russia Neurocognitive Assessment And Rehabilitation Market by Providers
6.2.3.5 Spain Neurocognitive Assessment And Rehabilitation Market
6.2.3.5.1 Spain Neurocognitive Assessment And Rehabilitation Market by Component
6.2.3.5.2 Spain Neurocognitive Assessment And Rehabilitation Market by Providers
6.2.3.6 Italy Neurocognitive Assessment And Rehabilitation Market
6.2.3.6.1 Italy Neurocognitive Assessment And Rehabilitation Market by Component
6.2.3.6.2 Italy Neurocognitive Assessment And Rehabilitation Market by Providers
6.2.3.7 Rest of Europe Neurocognitive Assessment And Rehabilitation Market
6.2.3.7.1 Rest of Europe Neurocognitive Assessment And Rehabilitation Market by Component
6.2.3.7.2 Rest of Europe Neurocognitive Assessment And Rehabilitation Market by Providers
6.3 Asia Pacific Neurocognitive Assessment And Rehabilitation Market
6.3.1 Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Component
6.3.1.1 Asia Pacific Neurorehabilitation Therapy Market by Country
6.3.1.2 Asia Pacific Neurocognitive Assessment Testing Market by Country
6.3.2 Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Providers
6.3.2.1 Asia Pacific Rehab Centers Market by Country
6.3.2.2 Asia Pacific Hospital & Clinics Market by Country
6.3.2.3 Asia Pacific Homecare Settings Market by Country
6.3.2.4 Asia Pacific Physiotherapy Centers Market by Country
6.3.3 Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Country
6.3.3.1 China Neurocognitive Assessment And Rehabilitation Market
6.3.3.1.1 China Neurocognitive Assessment And Rehabilitation Market by Component
6.3.3.1.2 China Neurocognitive Assessment And Rehabilitation Market by Providers
6.3.3.2 Japan Neurocognitive Assessment And Rehabilitation Market
6.3.3.2.1 Japan Neurocognitive Assessment And Rehabilitation Market by Component
6.3.3.2.2 Japan Neurocognitive Assessment And Rehabilitation Market by Providers
6.3.3.3 India Neurocognitive Assessment And Rehabilitation Market
6.3.3.3.1 India Neurocognitive Assessment And Rehabilitation Market by Component
6.3.3.3.2 India Neurocognitive Assessment And Rehabilitation Market by Providers
6.3.3.4 South Korea Neurocognitive Assessment And Rehabilitation Market
6.3.3.4.1 South Korea Neurocognitive Assessment And Rehabilitation Market by Component
6.3.3.4.2 South Korea Neurocognitive Assessment And Rehabilitation Market by Providers
6.3.3.5 Singapore Neurocognitive Assessment And Rehabilitation Market
6.3.3.5.1 Singapore Neurocognitive Assessment And Rehabilitation Market by Component
6.3.3.5.2 Singapore Neurocognitive Assessment And Rehabilitation Market by Providers
6.3.3.6 Malaysia Neurocognitive Assessment And Rehabilitation Market
6.3.3.6.1 Malaysia Neurocognitive Assessment And Rehabilitation Market by Component
6.3.3.6.2 Malaysia Neurocognitive Assessment And Rehabilitation Market by Providers
6.3.3.7 Rest of Asia Pacific Neurocognitive Assessment And Rehabilitation Market
6.3.3.7.1 Rest of Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Component
6.3.3.7.2 Rest of Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Providers
6.4 LAMEA Neurocognitive Assessment And Rehabilitation Market
6.4.1 LAMEA Neurocognitive Assessment And Rehabilitation Market by Component
6.4.1.1 LAMEA Neurorehabilitation Therapy Market by Country
6.4.1.2 LAMEA Neurocognitive Assessment Testing Market by Country
6.4.2 LAMEA Neurocognitive Assessment And Rehabilitation Market by Providers
6.4.2.1 LAMEA Rehab Centers Market by Country
6.4.2.2 LAMEA Hospital & Clinics Market by Country
6.4.2.3 LAMEA Homecare Settings Market by Country
6.4.2.4 LAMEA Physiotherapy Centers Market by Country
6.4.3 LAMEA Neurocognitive Assessment And Rehabilitation Market by Country
6.4.3.1 Brazil Neurocognitive Assessment And Rehabilitation Market
6.4.3.1.1 Brazil Neurocognitive Assessment And Rehabilitation Market by Component
6.4.3.1.2 Brazil Neurocognitive Assessment And Rehabilitation Market by Providers
6.4.3.2 Argentina Neurocognitive Assessment And Rehabilitation Market
6.4.3.2.1 Argentina Neurocognitive Assessment And Rehabilitation Market by Component
6.4.3.2.2 Argentina Neurocognitive Assessment And Rehabilitation Market by Providers
6.4.3.3 UAE Neurocognitive Assessment And Rehabilitation Market
6.4.3.3.1 UAE Neurocognitive Assessment And Rehabilitation Market by Component
6.4.3.3.2 UAE Neurocognitive Assessment And Rehabilitation Market by Providers
6.4.3.4 Saudi Arabia Neurocognitive Assessment And Rehabilitation Market
6.4.3.4.1 Saudi Arabia Neurocognitive Assessment And Rehabilitation Market by Component
6.4.3.4.2 Saudi Arabia Neurocognitive Assessment And Rehabilitation Market by Providers
6.4.3.5 South Africa Neurocognitive Assessment And Rehabilitation Market
6.4.3.5.1 South Africa Neurocognitive Assessment And Rehabilitation Market by Component
6.4.3.5.2 South Africa Neurocognitive Assessment And Rehabilitation Market by Providers
6.4.3.6 Nigeria Neurocognitive Assessment And Rehabilitation Market
6.4.3.6.1 Nigeria Neurocognitive Assessment And Rehabilitation Market by Component
6.4.3.6.2 Nigeria Neurocognitive Assessment And Rehabilitation Market by Providers
6.4.3.7 Rest of LAMEA Neurocognitive Assessment And Rehabilitation Market
6.4.3.7.1 Rest of LAMEA Neurocognitive Assessment And Rehabilitation Market by Component
6.4.3.7.2 Rest of LAMEA Neurocognitive Assessment And Rehabilitation Market by Providers
Chapter 7. Company Profiles
7.1 Cambridge Cognition Holdings PLC
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Cognifit, Inc.
7.2.1 Company Overview
7.3 Cogstate Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 SWOT Analysis
7.4 Lumos Labs, Inc. (Lumosity)
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 CNS Vital Signs, LLC
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 Posit Science Corporation
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 BrainCheck, Inc.
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Constant Therapy Health
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Trials and Approvals:
7.8.3 SWOT Analysis
7.9 NeuronUP SL
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. SCHUHFRIED GmbH
7.10.1 Company Overview
7.10.2 SWOT Analysis
Chapter 8. Winning Imperatives of Neurocognitive Assessment and Rehabilitation Market

Companies Mentioned

  • Cambridge Cognition Holdings plc
  • Cognifit, Inc.
  • Cogstate Ltd.
  • Lumos Labs, Inc. (Lumosity)
  • CNS Vital Signs, LLC
  • Posit Science Corporation
  • BrainCheck, Inc.
  • Constant Therapy Health
  • NeuronUP SL
  • SCHUHFRIED GmbH

Methodology

Loading
LOADING...